Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China · Delayed Price · Currency is CNY 41.70
-0.99 (-2.32%)
Jun 24, 2026, 3:04 PM CST
SHE:300832 Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, SHE:300832 stock has a consensus rating of "Strong Buy" and an average price target of ¥64.71. The average 1-year stock price forecast is 55.18% higher than the current stock price, while the lowest is ¥54.86 (+31.56%) and the highest is ¥74.10 (+77.70%).
Price Target: ¥64.71 (+55.18%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHE:300832 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 10 | 11 | 10 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 13 | 13 | 13 | 14 | 13 |
Financial Forecast
Revenue This Year
5.10B
from 4.58B
Increased by 11.52%
Revenue Next Year
5.84B
from 5.10B
Increased by 14.49%
EPS This Year
2.27
from 1.99
Increased by 14.02%
EPS Next Year
2.74
from 2.27
Increased by 20.80%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 5.2B | ||
| Avg | 5.1B | ||
| Low | 5.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 13.7% | ||
| Avg | 11.5% | ||
| Low | 8.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.28 | ||
| Avg | 2.27 | ||
| Low | 2.26 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.6% | ||
| Avg | 14.0% | ||
| Low | 13.5% |